Mutation analysis of patients with neurodegenerative disorders using NeuroX array

Neurobiology of Aging

Volumn 36, Issue 1, 2015, Pages 545.e9-545.e14

  Ghani, Mahdi ^a   Lang, Anthony E ^a,b,c   Zinman, Lorne ^c,d   Nacmias, Benedetta ^e   Sorbi, Sandro ^e   Bessi, Valentina ^e   Tedde, Andrea ^e   Tartaglia, Maria Carmela ^a,c   Surace, Ezequiel I ^f   Sato, Christine ^a   Moreno, Danielle ^a   Xi, Zhengrui ^a   Hung, Rachel ^a   Nalls, Mike A ^g   Singleton, Andrew ^g   St George Hyslop, Peter ^a,c,h   Rogaeva, Ekaterina ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF FLORENCE   (Italy)

^f Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

^g NATIONAL INSTITUTE ON AGING   (United States)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Mutation; Neurodegenerative disorder; NeuroX

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; LEUCINE RICH REPEAT KINASE 2; PRESENILIN 1; ABC TRANSPORTER; ABCA7 PROTEIN, HUMAN; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; PSEN1 PROTEIN, HUMAN; SUPEROXIDE DISMUTASE;

ABCA7 GENE; ADULT; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA MICROARRAY; FRONTOTEMPORAL DEMENTIA; GENE; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; LRRK2 GENE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PARKINSON DISEASE; PSEN1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOD1 GENE; TREM2 GENE; AGED; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC VARIATION; GENETICS; MALE; MIDDLE AGED; PROCEDURES;

AGED; ATP-BINDING CASSETTE TRANSPORTERS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PRESENILIN-1; PROTEIN-SERINE-THREONINE KINASES; SUPEROXIDE DISMUTASE;

EID: 84920422782     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.07.038     Document Type: Article

References (40)

1. Arguelles S., Venero J.L., Garcia-Rodriguez S., Tomas-Camardiel M., Ayala A., Cano J., Machado A. Use of haptoglobin and transthyretin as potential biomarkers for the preclinical diagnosis of Parkinson's disease. Neurochem. Int. 2010, 57:227-234.
2. Battistini S., Ricci C., Giannini F., Calzavara S., Greco G., Del Corona A., Mancuso M., Battistini N., Siciliano G., Carrera P. G41S SOD1 mutation: a common ancestor for six ALS Italian families with an aggressive phenotype. Amyotroph. Lateral Scler. 2010, 11:210-215.
3. Benitez B.A., Cruchaga C. TREM2 and neurodegenerative disease. N.Engl. J. Med. 2013, 369:1567-1568.
4. Bettens K., Brouwers N., Engelborghs S., Lambert J.C., Rogaeva E., Vandenberghe R., Le Bastard N., Pasquier F., Vermeulen S., Van Dongen J., Mattheijssens M., Peeters K., Mayeux R., St George-Hyslop P., Amouyel P., De Deyn P.P., Sleegers K., Van Broeckhoven C. Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk. Mol. Neurodegener. 2012, 7:3.
5. Cady J., Koval E.D., Benitez B.A., Zaidman C., Jockel-Balsarotti J., Allred P., Baloh R.H., Ravits J., Simpson E., Appel S.H., Pestronk A., Goate A.M., Miller T.M., Cruchaga C., Harms M.B. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA Neurol. 2014, 71:449-453.
6. Campion D., Dumanchin C., Hannequin D., Dubois B., Belliard S., Puel M., Thomas-Anterion C., Michon A., Martin C., Charbonnier F., Raux G., Camuzat A., Penet C., Mesnage V., Martinez M., Clerget-Darpoux F., Brice A., Frebourg T. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am. J. Hum. Genet. 1999, 65:664-670.
7. Chen Y.Z., Bennett C.L., Huynh H.M., Blair I.P., Puls I., Irobi J., Dierick I., Abel A., Kennerson M.L., Rabin B.A., Nicholson G.A., Auer-Grumbach M., Wagner K., De Jonghe P., Griffin J.W., Fischbeck K.H., Timmerman V., Cornblath D.R., Chance P.F. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 2004, 74:1128-1135.
8. Cook E.H., Scherer S.W. Copy-number variations associated with neuropsychiatric conditions. Nature 2008, 455:919-923.
9. Eymard-Pierre E., Yamanaka K., Haeussler M., Kress W., Gauthier-Barichard F., Combes P., Cleveland D.W., Boespflug-Tanguy O. Novel missense mutation in ALS2 gene results in infantile ascending hereditary spastic paralysis. Ann. Neurol. 2006, 59:976-980.
10. Ghani M., Pinto D., Lee J.H., Grinberg Y., Sato C., Moreno D., Scherer S.W., Mayeux R., St George-Hyslop P., Rogaeva E. Genome-wide survey of large rare copy number variants in Alzheimer's disease among Caribbean Hispanics. G3 (Bethesda) 2012, 2:71-78.
11. Ghani M., Rogaeva E. Autosomal dominant Alzheimer's disease: underlying causes. Neurodegenerative Diseases 2014, 27-47. Springer, London. D. Galimberti, E. Scarpini (Eds.).
12. Ghani M., Sato C., Lee J.H., Reitz C., Moreno D., Mayeux R., St George-Hyslop P., Rogaeva E. Evidence of recessive Alzheimer disease loci in a Caribbean Hispanic data set: genome-wide survey of runs of homozygosity. JAMA Neurol. 2013, 70:1261-1267.
13. Ghani M., Sato C., Rogaeva E. Segmental duplications in genome-wide significant loci and housekeeping genes; warning for GAPDH and ACTB. Neurobiol. Aging 2013, 34:1710.e1-1710.e4.
14. Guerreiro R., Bras J., Hardy J., Singleton A. Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations. Hum. Mol. Genet. 2014, pii: ddu203. [Epub ahead of print].
15. Guerreiro R.J., Baquero M., Blesa R., Boada M., Bras J.M., Bullido M.J., Calado A., Crook R., Ferreira C., Frank A., Gomez-Isla T., Hernandez I., Lleo A., Machado A., Martinez-Lage P., Masdeu J., Molina-Porcel L., Molinuevo J.L., Pastor P., Perez-Tur J., Relvas R., Oliveira C.R., Ribeiro M.H., Rogaeva E., Sa A., Samaranch L., Sanchez-Valle R., Santana I., Tarraga L., Valdivieso F., Singleton A., Hardy J., Clarimon J. Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol. Aging 2010, 31:725-731.
16. Guerreiro R., Wojtas A., Bras J., Carrasquillo M., Rogaeva E., Majounie E., Cruchaga C., Sassi C., Kauwe J.S., Younkin S., Hazrati L., Collinge J., Pocock J., Lashley T., Williams J., Lambert J.C., Amouyel P., Goate A., Rademakers R., Morgan K., Powell J., St George-Hyslop P., Singleton A., Hardy J. TREM2 variants in Alzheimer's disease. N.Engl. J. Med. 2013, 368:117-127.
17. Hadano S., Hand C.K., Osuga H., Yanagisawa Y., Otomo A., Devon R.S., Miyamoto N., Showguchi-Miyata J., Okada Y., Singaraja R., Figlewicz D.A., Kwiatkowski T., Hosler B.A., Sagie T., Skaug J., Nasir J., Brown R.H., Scherer S.W., Rouleau G.A., Hayden M.R., Ikeda J.E. Agene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 2001, 29:166-173.
18. Hardy J., Rogaeva E. Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not. Exp. Neurol. 2013, pii: S0014-4886(13)00330-0. doi: 10.1016/j.expneurol.2013.11.006. [Epub ahead of print].
19. Atwo-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet. 2011, 7:e1002142. International Parkinson's Disease Genomics Consortium (IPDGC); Wellcome Trust Case Control Consortium 2 (WTCCC2).
20. Kara E., Xiromerisiou G., Spanaki C., Bozi M., Koutsis G., Panas M., Dardiotis E., Ralli S., Bras J., Letson C., Edsall C., Pliner H., Arepalli S., Kalinderi K., Fidani L., Bostantjopoulou S., Keller M.F., Wood N.W., Hardy J., Houlden H., Stefanis L., Plaitakis A., Hernandez D., Hadjigeorgiou G.M., Nalls M.A., Singleton A.B. Assessment of Parkinson's disease risk loci in Greece. Neurobiol. Aging 2014, 35:442.e9-442.e16.
21. Kwok J.B., Taddei K., Hallupp M., Fisher C., Brooks W.S., Broe G.A., Hardy J., Fulham M.J., Nicholson G.A., Stell R., St George Hyslop P.H., Fraser P.E., Kakulas B., Clarnette R., Relkin N., Gandy S.E., Schofield P.R., Martins R.N. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport 1997, 8:1537-1542.
22. Lambert J.C., Ibrahim-Verbaas C.A., Harold D., Naj A.C., Sims R., Bellenguez C., DeStafano A.L., Bis J.C., Beecham G.W., Grenier-Boley B., Russo G., Thorton-Wells T.A., Jones N., Smith A.V., Chouraki V., Thomas C., Ikram M.A., Zelenika D., Vardarajan B.N., Kamatani Y., Lin C.F., Gerrish A., Schmidt H., Kunkle B., Dunstan M.L., Ruiz A., Bihoreau M.T., Choi S.H., Reitz C., Pasquier F., Cruchaga C., Craig D., Amin N., Berr C., Lopez O.L., De Jager P.L., Deramecourt V., Johnston J.A., Evans D., Lovestone S., Letenneur L., Moron F.J., Rubinsztein D.C., Eiriksdottir G., Sleegers K., Goate A.M., Fievet N., Huentelman M.W., Gill M., Brown K., Kamboh M.I., Keller L., Barberger-Gateau P., McGuiness B., Larson E.B., Green R., Myers A.J., Dufouil C., Todd S., Wallon D., Love S., Rogaeva E., Gallacher J., St George-Hyslop P., Clarimon J., Lleo A., Bayer A., Tsuang D.W., Yu L., Tsolaki M., Bossu P., Spalletta G., Proitsi P., Collinge J., Sorbi S., Sanchez-Garcia F., Fox N.C., Hardy J., Deniz Naranjo M.C., Bosco P., Clarke R., Brayne C., Galimberti D., Mancuso M., Matthews F., Moebus S., Mecocci P., Del Zompo M., Maier W., Hampel H., Pilotto A., Bullido M., Panza F., Caffarra P., Nacmias B., Gilbert J.R., Mayhaus M., Lannefelt L., Hakonarson H., Pichler S., Carrasquillo M.M., Ingelsson M., Beekly D., Alvarez V., Zou F., Valladares O., Younkin S.G., Coto E., Hamilton-Nelson K.L., Gu W., Razquin C., Pastor P., Mateo I., Owen M.J., Faber K.M., Jonsson P.V., Combarros O., O'Donovan M.C., Cantwell L.B., Soininen H., Blacker D., Mead S., Mosley T.H., Bennett D.A., Harris T.B., Fratiglioni L., Holmes C., de Bruijn R.F., Passmore P., Montine T.J., Bettens K., Rotter J.I., Brice A., Morgan K., Foroud T.M., Kukull W.A., Hannequin D., Powell J.F., Nalls M.A., Ritchie K., Lunetta K.L., Kauwe J.S., Boerwinkle E., Riemenschneider M., Boada M., Hiltuenen M., Martin E.R., Schmidt R., Rujescu D., Wang L.S., Dartigues J.F., Mayeux R., Tzourio C., Hofman A., Nothen M.M., Graff C., Psaty B.M., Jones L., Haines J.L., Holmans P.A., Lathrop M., Pericak-Vance M.A., Launer L.J., Farrer L.A., van Duijn C.M., Van Broeckhoven C., Moskvina V., Seshadri S., Williams J., Schellenberg G.D., Amouyel P. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 2013, 45:1452-1458.
23. Li H., Wang B., Wang Z., Guo Q., Tabuchi K., Hammer R.E., Sudhof T.C., Zheng H. Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP. Proc. Natl. Acad. Sci. U.S.A 2010, 107:17362-17367.
24. Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 2013, 79:416-438.
25. Marras C., Klein C., Lang A.E., Wakutani Y., Moreno D., Sato C., Yip E., Munhoz R.P., Lohmann K., Djarmati A., Bi A., Rogaeva E. LRRK2 and Parkin mutations in a family with parkinsonism-lack of genotype-phenotype correlation. Neurobiol. Aging 2010, 31:721-722.
26. Mullaney J.M., Mills R.E., Pittard W.S., Devine S.E. Small insertions and deletions (INDELs) in human genomes. Hum. Mol. Genet. 2010, 19:R131-R136.
27. Nalls M.A., Bras J., Hernandez D.G., Keller M.F., Majounie E., Alan E., Renton M.S., Jansen I., Guerreiro R., Lubbe S., Vincent Plagnol J., Gibbs R., Schulte C., Pankratz N., Sutherland M., Bertram L., Lill C., DeStefano A.L., Faroud T., Eriksson N., Tung J.Y., Edsall C., Nichols N., Brooks J., Arepalli S., Pliner H., Letson C., Heutink P., Martinez M., Gasser T., Traynor B.J., Wood N., Hardy J., Singleton A.B. NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases. Neurobiol. Aging 2014, on behalf of the International Parkinson's Disease Genomics Consortium (IPDGC) and the Parkinson's Disease meta-analysis consortium, (in press). doi:10.1016/j.neurobiolaging.2014.07.028.
28. Nalls M.A., Plagnol V., Hernandez D.G., Sharma M., Sheerin U.M., Saad M., Simon-Sanchez J., Schulte C., Lesage S., Sveinbjornsdottir S., Stefansson K., Martinez M., Hardy J., Heutink P., Brice A., Gasser T., Singleton A.B., Wood N.W. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377:641-649.
29. Niemann S., Joos H., Meyer T., Vielhaber S., Reuner U., Gleichmann M., Dengler R., Muller U. Familial ALS in Germany: origin of the R115G SOD1 mutation by a founder effect. J.Neurol. Neurosurg. Psychiatry 2004, 75:1186-1188.
30. Park H.K., Na D.L., Lee J.H., Kim J.W., Ki C.S. Identification of PSEN1 and APP gene mutations in Korean patients with early-onset Alzheimer's disease. J.Korean Med. Sci. 2008, 23:213-217.
31. Raux G., Guyant-Marechal L., Martin C., Bou J., Penet C., Brice A., Hannequin D., Frebourg T., Campion D. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J.Med. Genet. 2005, 42:793-795.
32. Rayaprolu S., Mullen B., Baker M., Lynch T., Finger E., Seeley W.W., Hatanpaa K.J., Lomen-Hoerth C., Kertesz A., Bigio E.H., Lippa C., Josephs K.A., Knopman D.S., White C.L., Caselli R., Mackenzie I.R., Miller B.L., Boczarska-Jedynak M., Opala G., Krygowska-Wajs A., Barcikowska M., Younkin S.G., Petersen R.C., Ertekin-Taner N., Uitti R.J., Meschia J.F., Boylan K.B., Boeve B.F., Graff-Radford N.R., Wszolek Z.K., Dickson D.W., Rademakers R., Ross O.A. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol. Neurodegener. 2013, 8:19.
33. Singleton A.B., Farrer M.J., Bonifati V. The genetics of Parkinson's disease: progress and therapeutic implications. Mov. Disord. 2013, 28:14-23.
34. Stankiewicz P., Lupski J.R. Structural variation in the human genome and its role in disease. Annu. Rev. Med. 2010, 61:437-455.
35. Toft M., Mata I.F., Ross O.A., Kachergus J., Hulihan M.M., Haugarvoll K., Stone J.T., Blazquez M., Gibson J.M., Aasly J.O., White L.R., Lynch T., Adler C.H., Gwinn-Hardy K., Farrer M.J. Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease. Mov. Disord. 2007, 22:389-392.
36. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304:1158-1160.
37. van Duijn C.M., Dekker M.C., Bonifati V., Galjaard R.J., Houwing-Duistermaat J.J., Snijders P.J., Testers L., Breedveld G.J., Horstink M., Sandkuijl L.A., van Swieten J.C., Oostra B.A., Heutink P. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am. J. Hum. Genet. 2001, 69:629-634.
38. Vardarajan B.N., Zhang Y., Lee J.H., Cheng R., Bohm C., Ghani M., Reitz C., Reyes-Dumeyer D., Shen Y., Rogaeva E., St George-Hyslop P., Mayeux R. Coding mutations in SORL1 and Alzheimer's disease. Ann. Neurol. 2014, (Under review).
39. Xi Z Y.Y., van Blitterswijk M., Dib S., Ghani M., Moreno D., Sato C., Liang Y., Singleton A., Robertson J., Rademakers R., Zinman L., Rogaeva E. Identical twins with the C9orf72 repeat expansion are discordant for ALS. Neurology 2014, (In Press).
40. Xi Z., Zinman L., Grinberg Y., Moreno D., Sato C., Bilbao J.M., Ghani M., Hernandez I., Ruiz A., Boada M., Moron F.J., Lang A.E., Marras C., Bruni A., Colao R., Maletta R.G., Puccio G., Rainero I., Pinessi L., Galimberti D., Morrison K.E., Moorby C., Stockton J.D., Masellis M., Black S.E., Hazrati L.N., Liang Y., van Haersma de With J., Fornazzari L., Villagra R., Rojas-Garcia R., Clarimon J., Mayeux R., Robertson J., St George-Hyslop P., Rogaeva E. Investigation of c9orf72 in 4 neurodegenerative disorders. Arch. Neurol. 2012, 69:1583-1590.